humanitarian
Human medicines European public assessment report (EPAR): Yesintek, ustekinumab, Date of authorisation: 14/02/2025, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Oncaspar, pegaspargase, Date of authorisation: 14/01/2016, Revision: 21, Status: Authorised
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
6 reports · 2 sources
EMA What Is NewHuman medicines European public assessment report (EPAR): Yesintek, ustekinumab, Date of authorisation: 14/02/2025, Revision: 5, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Yesintek, ustekinumab, Date of authorisation: 14/02/2025, Revision: 5, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Usrenty, ustekinumab, Date of authorisation: 17/09/2025, Revision: 3, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Usrenty, ustekinumab, Date of authorisation: 17/09/2025, Revision: 3, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Abiraterone Mylan, abiraterone acetate, Date of authorisation: 20/08/2021, Revision: 8, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Abiraterone Mylan, abiraterone acetate, Date of authorisation: 20/08/2021, Revision: 8, Status: Authorised3 recorded states
Signal first indexedP2 · 99% quality · 2 sources
Headline updatedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources